These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 7664505)

  • 21. Randomized, double-blind, placebo-controlled long-term study of isosorbide-5-mononitrate therapy in patients with left ventricular dysfunction after acute myocardial infarction.
    Tingberg E; Roijer A; Thilen U; Eskilsson J; Ohlin H
    Am Heart J; 2003 Jan; 145(1):E1. PubMed ID: 12514673
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Atrial natriuretic peptide in patients with acute myocardial infarction].
    Górecki A
    Pol Arch Med Wewn; 1993 Oct; 90(4):260-6. PubMed ID: 8127791
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of enalapril on mortality and the development of heart failure in asymptomatic patients with reduced left ventricular ejection fractions.
    ; Yusuf S; Pitt B; Davis CE; Hood WB; Cohn JN
    N Engl J Med; 1992 Sep; 327(10):685-91. PubMed ID: 1463530
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Neurohumoral changes in patients with left ventricular dysfunction following acute myocardial infarction and the effect of nitrate therapy: a randomized, double-blind, placebo-controlled long-term study.
    Tingberg E; Roijer A; Thilen U; Ohlin H
    J Cardiovasc Pharmacol; 2006 Oct; 48(4):166-72. PubMed ID: 17086095
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Atrial natriuretic peptide ANP(1-98) and ANP(99-126) in patients with severe chronic congestive heart failure: relation to echocardiographic measurements. A subgroup analysis from the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS).
    Eriksson SV; Caidahl K; Hall C; Eneroth P; Kjekshus J; Offstad J; Swedberg K
    J Card Fail; 1995 Mar; 1(2):109-16. PubMed ID: 9420640
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Noninvasive assessment of left ventricular filling pressure after acute myocardial infarction: a prospective study of the relative prognostic utility of clinical assessment, echocardiography, and B-type natriuretic peptide.
    Kruszewski K; Scott AE; Barclay JL; Small GR; Croal BL; Møller JE; Oh JK; Hillis GS
    Am Heart J; 2010 Jan; 159(1):47-54. PubMed ID: 20102866
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prognosis in myocardial infarction patients with heart failure and normal or mildly impaired systolic function.
    Jarnert C; Edner M; Persson HE
    Int J Cardiol; 2007 Apr; 117(2):184-90. PubMed ID: 16860417
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Long-term effects on cardiac output and peripheral resistance in patients treated with enalapril after acute myocardial infarction. CONSENSUS II Multi-Echo Study Group. Cooperative New Scandinavian Enalapril Survival Study.
    Edner M; Caidahl K; Bonarjee VV; Nilsen DW; Carstensen S; Berning J
    Cardiology; 1998 May; 89(4):291-6. PubMed ID: 9643277
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Treatment with ramipril improves systolic function even in patients with mild systolic dysfunction and symptoms of heart failure after acute myocardial infarction.
    Kongstad-Rasmussen O; Blomstrand P; Broqvist M; Dahlström U; Wranne B
    Clin Cardiol; 1998 Nov; 21(11):807-11. PubMed ID: 9825192
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of angiotensin-converting enzyme inhibitors on ventricular remodeling and survival following myocardial infarction.
    Beckwith C; Munger MA
    Ann Pharmacother; 1993 Jun; 27(6):755-66. PubMed ID: 8329800
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Enalapril and carvedilol for preventing chemotherapy-induced left ventricular systolic dysfunction in patients with malignant hemopathies: the OVERCOME trial (preventiOn of left Ventricular dysfunction with Enalapril and caRvedilol in patients submitted to intensive ChemOtherapy for the treatment of Malignant hEmopathies).
    Bosch X; Rovira M; Sitges M; Domènech A; Ortiz-Pérez JT; de Caralt TM; Morales-Ruiz M; Perea RJ; Monzó M; Esteve J
    J Am Coll Cardiol; 2013 Jun; 61(23):2355-62. PubMed ID: 23583763
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of long-term enalapril therapy on neurohormones in patients with left ventricular dysfunction. SOLVD Investigators.
    Benedict CR; Francis GS; Shelton B; Johnstone DE; Kubo SH; Kirlin P; Nicklas J; Liang CS; Konstam MA; Greenberg B
    Am J Cardiol; 1995 Jun; 75(16):1151-7. PubMed ID: 7762503
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Two-year time course and significance of neurohumoral activation in the Survival and Ventricular Enlargement (SAVE) Study.
    Vantrimpont P; Rouleau JL; Ciampi A; Harel F; de Champlain J; Bichet D; Moyé LA; Pfeffer M
    Eur Heart J; 1998 Oct; 19(10):1552-63. PubMed ID: 9820995
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of enalapril on plasma atrial natriuretic peptide in late recovery phase of acute myocardial infarction.
    Hirvonen T; Remes J; Mustonen J; Tikkanen I; Tenhunen M; Pyörälä K
    Ann Med; 1991 Aug; 23(3):271-5. PubMed ID: 1834093
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Potential proischemic effect of early enalapril in hypotension-prone patients with acute myocardial infarction. The CONSENSUS II Holter Substudy Group.
    Søgaard P; Thygesen K
    Cardiology; 1997; 88(3):285-91. PubMed ID: 9129851
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Management of asymptomatic left ventricular dysfunction.
    Haas GJ
    Cleve Clin J Med; 2001 Mar; 68(3):249-55. PubMed ID: 11263853
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Early treatment with captopril after acute myocardial infarction.
    Ray SG; Pye M; Oldroyd KG; Christie J; Connelly DT; Northridge DB; Ford I; Morton JJ; Dargie HJ; Cobbe SM
    Br Heart J; 1993 Mar; 69(3):215-22. PubMed ID: 8461219
    [TBL] [Abstract][Full Text] [Related]  

  • 38. N-terminal pro-atrial natriuretic peptide (N-ANP) and N-terminal pro-B-type natriuretic peptide (N-BNP) in the prediction of death and heart failure in unselected patients following acute myocardial infarction.
    Squire IB; O'Brien RJ; Demme B; Davies JE; Ng LL
    Clin Sci (Lond); 2004 Sep; 107(3):309-16. PubMed ID: 15182235
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Abnormal glucose metabolism in acute myocardial infarction: influence on left ventricular function and prognosis.
    Høfsten DE; Løgstrup BB; Møller JE; Pellikka PA; Egstrup K
    JACC Cardiovasc Imaging; 2009 May; 2(5):592-9. PubMed ID: 19442946
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Extracellular cardiac matrix biomarkers in patients with acute myocardial infarction complicated by left ventricular dysfunction and heart failure: insights from the Eplerenone Post-Acute Myocardial Infarction Heart Failure Efficacy and Survival Study (EPHESUS) study.
    Iraqi W; Rossignol P; Angioi M; Fay R; Nuée J; Ketelslegers JM; Vincent J; Pitt B; Zannad F
    Circulation; 2009 May; 119(18):2471-9. PubMed ID: 19398668
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.